D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 105 Citations 49,251 396 World Ranking 3930 National Ranking 156

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

Patrick S. Parfrey mainly focuses on Internal medicine, Surgery, Cardiology, Kidney disease and Genetics. His Internal medicine study frequently draws parallels with other fields, such as Endocrinology. His Surgery research incorporates themes from Diabetes mellitus, Creatinine and Myocardial infarction.

His Cardiology study integrates concerns from other disciplines, such as Prospective cohort study and Left ventricular hypertrophy. Patrick S. Parfrey has included themes like Hazard ratio, Nephropathy, Anemia and Intensive care medicine in his Kidney disease study. In the subject of general Genetics, his work in Genotype, PKD1, Autosomal dominant polycystic kidney disease and Germline mutation is often linked to BBS2, thereby combining diverse domains of study.

His most cited work include:

  • Clinical epidemiology of cardiovascular disease in chronic renal disease. (3311 citations)
  • A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease (1490 citations)
  • Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. (874 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Kidney disease, Cardiology, Surgery and Intensive care medicine. His study in Internal medicine focuses on Hemodialysis, Dialysis, Heart failure, Anemia and Colorectal cancer. The Hemodialysis study which covers Cinacalcet that intersects with Cinacalcet Hydrochloride, Clinical trial and Calcimimetic.

In his research on the topic of Kidney disease, Renal function is strongly related with Diabetes mellitus. His work investigates the relationship between Cardiology and topics such as Disease that intersect with problems in Dialysis patients. His Surgery research integrates issues from Muscle hypertrophy and Kidney.

He most often published in these fields:

  • Internal medicine (55.44%)
  • Kidney disease (19.95%)
  • Cardiology (20.21%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (55.44%)
  • Colorectal cancer (13.21%)
  • Hemodialysis (15.03%)

In recent papers he was focusing on the following fields of study:

Patrick S. Parfrey mostly deals with Internal medicine, Colorectal cancer, Hemodialysis, Cinacalcet and Kidney disease. The concepts of his Internal medicine study are interwoven with issues in Oncology and Cardiology. In his research, Renal function is intimately related to Framingham Risk Score, which falls under the overarching field of Cardiology.

His research in Hemodialysis tackles topics such as Physical therapy which are related to areas like Medical record, Low back pain and Quality of life. His research integrates issues of Anemia, Intensive care medicine, Dialysis, Type 2 diabetes and Risk factor in his study of Kidney disease. His Cinacalcet Hydrochloride research is multidisciplinary, incorporating perspectives in Endocrinology, Surgery and Intention-to-treat analysis.

Between 2013 and 2021, his most popular works were:

  • Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis : The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial (186 citations)
  • Discovery of common and rare genetic risk variants for colorectal cancer (131 citations)
  • Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial (108 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Patrick S. Parfrey mainly investigates Internal medicine, Cinacalcet, Hemodialysis, Kidney disease and Cinacalcet Hydrochloride. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Cardiology. The Hemodialysis study combines topics in areas such as Secondary hyperparathyroidism and Hyperphosphatemia.

Patrick S. Parfrey interconnects Nephrology, Diabetes mellitus, Type 2 diabetes, Intensive care medicine and Risk factor in the investigation of issues within Kidney disease. The study incorporates disciplines such as Etelcalcetide, Surgery and Intention-to-treat analysis in addition to Cinacalcet Hydrochloride. His Surgery study incorporates themes from Economic evaluation and Emergency medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical epidemiology of cardiovascular disease in chronic renal disease.

Robert N. Foley;Patrick S. Parfrey;Mark J. Sarnak.
American Journal of Kidney Diseases (1998)

5875 Citations

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper.
The New England Journal of Medicine (2009)

2176 Citations

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

Robert N. Foley;Patrick S. Parfrey;Patrick S. Parfrey;John D. Harnett;John D. Harnett;Gloria M. Kent;Gloria M. Kent.
Kidney International (1995)

1746 Citations

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study.

Patrick S. Parfrey;Sheila M. Griffiths;Brendan J. Barrett;Michael D. Paul.
The New England Journal of Medicine (1989)

1427 Citations

Epidemiology of cardiovascular disease in chronic renal disease.

Foley Rn;Parfrey Ps;Sarnak Mj.
Journal of The American Society of Nephrology (1998)

1424 Citations

The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease☆

Robert N. Foley;Patrick S. Parfrey;Patrick S. Parfrey;John D. Harnett;John D. Harnett;Gloria M. Kent;Gloria M. Kent.
American Journal of Kidney Diseases (1996)

1065 Citations

Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors

John D. Harnett;Robert N. Foley;Gloria M. Kent;Paul E. Barre.
Kidney International (1995)

932 Citations

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

Evolve Trial Investigators;Chertow Gm;Block Ga;Correa-Rotter R.
The New England Journal of Medicine (2012)

893 Citations

Preventing Nephropathy Induced by Contrast Medium

Brendan J. Barrett;Patrick S. Parfrey.
The New England Journal of Medicine (2006)

884 Citations

The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure

Patrick S. Parfrey;Robert N. Foley.
Journal of The American Society of Nephrology (1999)

834 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Patrick S. Parfrey

Kamyar Kalantar-Zadeh

Kamyar Kalantar-Zadeh

University of California, Irvine

Publications: 116

Polly A. Newcomb

Polly A. Newcomb

Fred Hutchinson Cancer Research Center

Publications: 113

Peter Stenvinkel

Peter Stenvinkel

Karolinska Institute

Publications: 111

David W. Johnson

David W. Johnson

University of Queensland

Publications: 103

John D. Potter

John D. Potter

Fred Hutchinson Cancer Research Center

Publications: 101

Bengt Lindholm

Bengt Lindholm

Karolinska Institute

Publications: 97

Carmine Zoccali

Carmine Zoccali

National Academies of Sciences, Engineering, and Medicine

Publications: 97

Francesco Locatelli

Francesco Locatelli

University of Pavia

Publications: 90

Marcello Tonelli

Marcello Tonelli

University of Calgary

Publications: 87

Andrew T. Chan

Andrew T. Chan

Harvard University

Publications: 85

Adrian Covic

Adrian Covic

Grigore T. Popa University of Medicine and Pharmacy

Publications: 83

Glenn M. Chertow

Glenn M. Chertow

Stanford University

Publications: 83

Jonathan C. Craig

Jonathan C. Craig

Flinders University

Publications: 80

Mark A. Jenkins

Mark A. Jenkins

University of Melbourne

Publications: 77

Csaba P. Kovesdy

Csaba P. Kovesdy

University of Tennessee Health Science Center

Publications: 75

Alan G. Jardine

Alan G. Jardine

University of Glasgow

Publications: 73

Trending Scientists

Brad Hutchings

Brad Hutchings

Brigham Young University

Jasha Droppo

Jasha Droppo

Amazon (United States)

Michael Baake

Michael Baake

Bielefeld University

Andrea Carena

Andrea Carena

Polytechnic University of Turin

Xia Huang

Xia Huang

Tsinghua University

Tata N. Rao

Tata N. Rao

Arc International

Wolfgang Forstmeier

Wolfgang Forstmeier

Max Planck Society

Richard A. Phillips

Richard A. Phillips

British Antarctic Survey

Thomas E. Besser

Thomas E. Besser

Washington State University

Vincenzo Lapenna

Vincenzo Lapenna

National Academies of Sciences, Engineering, and Medicine

J. J. Margitan

J. J. Margitan

Jet Propulsion Lab

Janine I. Rossato

Janine I. Rossato

Federal University of Rio Grande do Norte

Anna W. Roe

Anna W. Roe

Zhejiang University

M. Catherine Bushnell

M. Catherine Bushnell

National Institutes of Health

K. Warner Schaie

K. Warner Schaie

University of Washington

Eva Syková

Eva Syková

Czech Academy of Sciences

Something went wrong. Please try again later.